Single-cell profiling reveals GABBR1 as a cuproptosis-regulated prognostic biomarker in pancreatic cancer.
Understanding a specific gene's role in pancreatic cancer opens new possibilities for targeting treatment sensitivity.
We performed integrated analyses of scRNA-seq data from patients with PC (GSE212966) and The Cancer Genome Atlas-pancreatic adenocarcinoma dataset. Modulating GABBR1 can reshape cuproptosis pathways, thereby influencing apoptotic sensitivity and modulating immune responses.
What the study was
- Study design
- Validation study
- Category
- Genomics/Precision Medicine
- Maturity
- Validated
- Journal
- iLIVER
Why it surfaced
⚪ PROMISING_PRELIMINARY — Promising but preliminary; Watchlist: Precision oncology and genomic medicine; Design: Validation study; species: unknown
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.